NL7211565A - - Google Patents

Info

Publication number
NL7211565A
NL7211565A NL7211565A NL7211565A NL7211565A NL 7211565 A NL7211565 A NL 7211565A NL 7211565 A NL7211565 A NL 7211565A NL 7211565 A NL7211565 A NL 7211565A NL 7211565 A NL7211565 A NL 7211565A
Authority
NL
Netherlands
Application number
NL7211565A
Other versions
NL176836C (nl
NL176836B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25761638&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL7211565(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE19722209526 external-priority patent/DE2209526C3/de
Application filed filed Critical
Publication of NL7211565A publication Critical patent/NL7211565A/xx
Publication of NL176836B publication Critical patent/NL176836B/xx
Application granted granted Critical
Publication of NL176836C publication Critical patent/NL176836C/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S206/00—Special receptacle or package
    • Y10S206/828—Medicinal content

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Hydrogenated Pyridines (AREA)
NLAANVRAGE7211565,A 1971-08-24 1972-08-24 Gelatine-capsule, die als werkzame stof het coronair werkzame 4-(2'-nitrofenyl)-2,6-dimethyl-3,5-di-methoxycarbonyl -1,4-dihydropyridine bevat. NL176836C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2142316 1971-08-24
DE19722209526 DE2209526C3 (de) 1972-02-29 1972-02-29 Coronartherapeutlkum in Form von Gelatine-BeiBkapseln

Publications (3)

Publication Number Publication Date
NL7211565A true NL7211565A (cg-RX-API-DMAC7.html) 1973-02-27
NL176836B NL176836B (nl) 1985-01-16
NL176836C NL176836C (nl) 1985-06-17

Family

ID=25761638

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7211565,A NL176836C (nl) 1971-08-24 1972-08-24 Gelatine-capsule, die als werkzame stof het coronair werkzame 4-(2'-nitrofenyl)-2,6-dimethyl-3,5-di-methoxycarbonyl -1,4-dihydropyridine bevat.

Country Status (25)

Country Link
US (1) US3784684A (cg-RX-API-DMAC7.html)
JP (2) JPS5434048B2 (cg-RX-API-DMAC7.html)
KR (1) KR780000433B1 (cg-RX-API-DMAC7.html)
BE (1) BE787951A (cg-RX-API-DMAC7.html)
BG (1) BG27728A3 (cg-RX-API-DMAC7.html)
CA (1) CA981582A (cg-RX-API-DMAC7.html)
CY (1) CY918A (cg-RX-API-DMAC7.html)
DD (1) DD99729A5 (cg-RX-API-DMAC7.html)
DK (1) DK130628B (cg-RX-API-DMAC7.html)
EG (1) EG10633A (cg-RX-API-DMAC7.html)
ES (1) ES406047A1 (cg-RX-API-DMAC7.html)
FI (1) FI53922C (cg-RX-API-DMAC7.html)
FR (1) FR2150848B1 (cg-RX-API-DMAC7.html)
GB (1) GB1362627A (cg-RX-API-DMAC7.html)
HK (1) HK44877A (cg-RX-API-DMAC7.html)
IE (1) IE36891B1 (cg-RX-API-DMAC7.html)
IL (1) IL40165A (cg-RX-API-DMAC7.html)
KE (1) KE2756A (cg-RX-API-DMAC7.html)
LU (1) LU65929A1 (cg-RX-API-DMAC7.html)
MY (1) MY7800003A (cg-RX-API-DMAC7.html)
NL (1) NL176836C (cg-RX-API-DMAC7.html)
NO (1) NO138167C (cg-RX-API-DMAC7.html)
RO (1) RO88521B (cg-RX-API-DMAC7.html)
SG (1) SG34877G (cg-RX-API-DMAC7.html)
SU (1) SU432703A3 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7409832A (nl) * 1973-07-20 1975-01-22 Scherer Ltd R P Werkwijze voor de bereiding van farmaceu- tische samenstellingen.

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA725808B (en) * 1971-08-24 1973-05-30 Bayer Ag A coronary agent in special form and processes for its manufacture
SU432703A3 (cg-RX-API-DMAC7.html) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер
US4198391A (en) * 1973-07-20 1980-04-15 R. P. Scherer Ltd. Pharmaceutical compositions
BE825842A (fr) * 1974-02-22 1975-08-21 Compositions pharmaceutiques comprenant de la digoxine
US4002718A (en) * 1974-10-16 1977-01-11 Arnar-Stone Laboratories, Inc. Gelatin-encapsulated digoxin solutions and method of preparing the same
US4056610A (en) * 1975-04-09 1977-11-01 Minnesota Mining And Manufacturing Company Microcapsule insecticide composition
JPS52151724A (en) * 1976-06-07 1977-12-16 Takeda Chem Ind Ltd Hard shell gelatin capsule
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
JPS5484023A (en) * 1977-12-19 1979-07-04 Teijin Ltd Soft capsule containing active vitamin d3, and its preparation
JPS5522645A (en) * 1978-08-07 1980-02-18 Fujisawa Pharmaceut Co Ltd Soft capsule for encapsulation of light-unstable compound
JPS5522631A (en) * 1978-08-07 1980-02-18 Ota Seiyaku Kk Readily absorbable nifedipine preparation
US5264446A (en) * 1980-09-09 1993-11-23 Bayer Aktiengesellschaft Solid medicament formulations containing nifedipine, and processes for their preparation
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
JPS5939827A (ja) * 1982-08-27 1984-03-05 Nitto Electric Ind Co Ltd 医療用外用部材
DE3307353C2 (de) * 1983-03-02 1985-01-31 R.P. Scherer GmbH, 6930 Eberbach Polyethylenglykolhaltige Weichgelatinekapsel und Verfahren zu ihrer Herstellung
GB8305693D0 (en) * 1983-03-02 1983-04-07 Scherer Ltd R P Pharmaceutical compositions
DE3307422A1 (de) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen
US4832952A (en) * 1983-07-07 1989-05-23 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant
US4620974A (en) * 1983-07-07 1986-11-04 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant
US4777048A (en) * 1983-07-07 1988-10-11 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant
EP0143857B1 (de) * 1983-11-30 1988-04-06 Siegfried Aktiengesellschaft Coronartherapeutikum in Form von Weichgelatine-Kapseln
DE3419130A1 (de) * 1984-05-23 1985-11-28 Bayer Ag, 5090 Leverkusen Nifedipinkombinationspraeparate und verfahren zu ihrer herstellung
DE3419129A1 (de) * 1984-05-23 1985-11-28 Bayer Ag, 5090 Leverkusen Nifedipinpraeparate und verfahren zu ihrer herstellung
US5266581A (en) * 1984-07-04 1993-11-30 Bayer Aktiengesellschaft Solid composition containing dihydropyridine, PVP and PVPP
EP0175671A1 (de) * 1984-08-23 1986-03-26 Kuhlemann & Co. Pharmazeutische Zubereitung sowie Verfahren zum Darreichen dieser pharmazeutischen Zubereitung
DE3438830A1 (de) * 1984-10-23 1986-04-30 Rentschler Arzneimittel Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung
DE3532129A1 (de) * 1985-09-10 1987-03-12 Bayer Ag Ss-carotin enthaltende gelatine
GB8522453D0 (en) * 1985-09-11 1985-10-16 Lilly Industries Ltd Chewable capsules
DE3544692A1 (de) * 1985-12-18 1987-06-19 Bayer Ag Dihydropyridinspray, verfahren zu seiner herstellung und seine pharmazeutische verwendung
US4689233A (en) * 1986-01-06 1987-08-25 Siegfried Aktiengesellschaft Coronary therapeutic agent in the form of soft gelatin capsules
US4656028A (en) * 1986-06-24 1987-04-07 Norcliff Thayer Inc. Encapsulated antacid
DE3636123A1 (de) * 1986-10-23 1988-05-05 Rentschler Arzneimittel Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
DE3645036A1 (de) * 1986-11-18 1989-01-05 Forschungsgesellschaft Rauchen Nikotinhaltiges mittel
GB8629761D0 (en) * 1986-12-12 1987-01-21 Harris Pharma Ltd Capsules
ATE68704T1 (de) * 1986-12-18 1991-11-15 Bauer Kurt Heinz Gegenueber lichteinfluss stabilisiertes nifedipin- konzentrat und verfahren zu seiner herstellung.
DE3714402A1 (de) * 1987-04-30 1988-11-10 Kali Chemie Pharma Gmbh Arzneimittelformulierung
DE3738236A1 (de) * 1987-11-11 1989-05-24 Euro Celtique Sa Beisskapsel
US4954346A (en) * 1988-06-08 1990-09-04 Ciba-Geigy Corporation Orally administrable nifedipine solution in a solid light resistant dosage form
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
CA2056032A1 (en) * 1990-11-29 1992-05-30 Minoru Aoki Hard capsule preparation
US5431916A (en) * 1993-04-29 1995-07-11 The Procter & Gamble Company Pharmaceutical compositions and process of manufacture thereof
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5641512A (en) * 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
DE69732412T2 (de) * 1996-04-12 2006-01-05 Novadel Pharma Inc. Bukales, polares spray
KR100321489B1 (ko) 1996-07-08 2002-10-09 에드워드 멘델 컴파니 인코포레이티드 고용량의불용성약물용서방성매트릭스
JP4730985B2 (ja) * 1997-09-10 2011-07-20 武田薬品工業株式会社 安定化された医薬製剤
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20050287075A1 (en) * 1997-10-01 2005-12-29 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20030077228A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
US20040136914A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US20050281752A1 (en) * 1997-10-01 2005-12-22 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20040136913A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing sumatriptan
US20030082107A1 (en) * 1997-10-01 2003-05-01 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
US7632517B2 (en) * 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20030190286A1 (en) * 1997-10-01 2003-10-09 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
US20030095927A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
US20050163719A1 (en) * 1997-10-01 2005-07-28 Dugger Harry A.Iii Buccal, polar and non-polar spray containing diazepam
US20040141923A1 (en) * 1997-10-01 2004-07-22 Dugger Harry A. Buccal, polar and non-polar spray containing alprazolam
US20050002867A1 (en) * 1997-10-01 2005-01-06 Novadel Pharma Inc. Buccal, polar and non-polar sprays containing propofol
US20030077227A1 (en) 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
EP1029536B1 (en) * 1997-10-01 2007-11-28 Novadel Pharma Inc. Buccal non-polar spray
US20040136915A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing atropine
US20050180923A1 (en) * 1997-10-01 2005-08-18 Dugger Harry A.Iii Buccal, polar and non-polar spray containing testosterone
US20030077229A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
US20090162300A1 (en) * 1997-10-01 2009-06-25 Dugger Iii Harry A Buccal, polar and non-polar spray containing alprazolam
US20030095925A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US20030102246A1 (en) * 1999-03-20 2003-06-05 Lts Lohmann Therapie-Systeme Ag Method for improving the stability of stored and/or used light-sensitive therapeutic systems or components thereof
JP4070459B2 (ja) 1999-08-31 2008-04-02 中外製薬株式会社 軟カプセル剤
NZ511900A (en) * 1999-09-30 2003-06-30 Penwest Pharmaceuticals Co Sustained release matrix systems for highly soluble drugs
US20030003144A1 (en) * 2001-05-01 2003-01-02 Keller Brian C. Sustained release formulations for nifedipine, dextromethorphan, and danazol
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
US8097279B2 (en) 2002-04-25 2012-01-17 Banner Pharmacaps Inc. Chewable soft capsule
JP5105705B2 (ja) * 2002-05-09 2012-12-26 中外製薬株式会社 光安定化軟カプセル剤
NZ566872A (en) * 2005-10-31 2010-12-24 Nissan Chemical Ind Ltd Pharmaceutical preparation having excellent photostability containing pitavastatin
US20070248548A1 (en) * 2006-04-19 2007-10-25 Blondino Frank E Stable hydroalcoholic oral spray formulations and methods
JP2010513525A (ja) * 2006-12-22 2010-04-30 ノヴァデル ファーマ インコーポレイテッド 安定な抗嘔吐経口噴霧製剤および方法
AU2008251370A1 (en) * 2007-05-10 2008-11-20 Novadel Pharma Inc. Anti-insomnia compositions and methods
US7985325B2 (en) * 2007-10-30 2011-07-26 Novellus Systems, Inc. Closed contact electroplating cup assembly
US8497303B2 (en) * 2008-01-18 2013-07-30 Dow Global Technologies Llc Method to enhance aqueous solubility of poorly soluble actives
CN102300563A (zh) * 2009-01-29 2011-12-28 大日本住友制药株式会社 具有内核的口腔崩解片剂
CN102160872A (zh) 2010-02-23 2011-08-24 天津天士力制药股份有限公司 复方丹参滴丸胶囊
TWI571257B (zh) * 2011-02-23 2017-02-21 Tasly Pharmaceutical Group Co Capsule preparation
JP7368383B2 (ja) 2018-05-14 2023-10-24 キャプシュゲル・ベルジウム・エヌ・ヴィ 不透明化剤を含むカプセル
EP3807892A1 (en) 2018-06-14 2021-04-21 AstraZeneca UK Limited Methods for lowering blood pressure with a dihydropyridine-type calcium channel blocker pharmaceutical composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2870061A (en) * 1956-11-08 1959-01-20 Mead Johnson & Co Concentrates of dialkyl sulfosuccinates
US3155587A (en) * 1963-01-23 1964-11-03 American Cyanamid Co Stable liquid preparations of 7-chlorotetracycline
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
SU432703A3 (cg-RX-API-DMAC7.html) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7409832A (nl) * 1973-07-20 1975-01-22 Scherer Ltd R P Werkwijze voor de bereiding van farmaceu- tische samenstellingen.

Also Published As

Publication number Publication date
LU65929A1 (cg-RX-API-DMAC7.html) 1973-01-15
JPS5434048B2 (cg-RX-API-DMAC7.html) 1979-10-24
JPS4828621A (cg-RX-API-DMAC7.html) 1973-04-16
DK130628B (da) 1975-03-17
FR2150848A1 (cg-RX-API-DMAC7.html) 1973-04-13
IE36891B1 (en) 1977-03-16
FI53922B (fi) 1978-05-31
HK44877A (en) 1977-09-09
JPS53121921A (en) 1978-10-24
KE2756A (en) 1977-10-14
CA981582A (en) 1976-01-13
ES406047A1 (es) 1981-08-16
IE36891L (en) 1973-02-24
FI53922C (fi) 1979-09-07
NL176836C (nl) 1985-06-17
DK130628C (cg-RX-API-DMAC7.html) 1975-08-25
SG34877G (en) 1987-04-03
IL40165A0 (en) 1972-10-29
BG27728A3 (en) 1979-12-12
SU432703A3 (cg-RX-API-DMAC7.html) 1974-06-15
KR780000433B1 (en) 1978-10-14
NO138167B (no) 1978-04-10
NL176836B (nl) 1985-01-16
BE787951A (fr) 1973-02-26
RO88521A (ro) 1987-04-30
MY7800003A (en) 1978-12-31
CY918A (en) 1977-12-23
FR2150848B1 (cg-RX-API-DMAC7.html) 1976-04-16
NO138167C (no) 1978-07-26
DD99729A5 (cg-RX-API-DMAC7.html) 1973-08-20
RO88521B (ro) 1987-05-01
EG10633A (en) 1976-08-31
IL40165A (en) 1975-03-13
GB1362627A (en) 1974-08-07
US3784684A (en) 1974-01-08

Similar Documents

Publication Publication Date Title
ATA136472A (cg-RX-API-DMAC7.html)
AR196074A1 (cg-RX-API-DMAC7.html)
AU2658571A (cg-RX-API-DMAC7.html)
AU2691671A (cg-RX-API-DMAC7.html)
AU2742671A (cg-RX-API-DMAC7.html)
AU2952271A (cg-RX-API-DMAC7.html)
AU2485671A (cg-RX-API-DMAC7.html)
AU2726271A (cg-RX-API-DMAC7.html)
AU3005371A (cg-RX-API-DMAC7.html)
AU2684071A (cg-RX-API-DMAC7.html)
AU2941471A (cg-RX-API-DMAC7.html)
AU2894671A (cg-RX-API-DMAC7.html)
AU2564071A (cg-RX-API-DMAC7.html)
AU2473671A (cg-RX-API-DMAC7.html)
AU2836771A (cg-RX-API-DMAC7.html)
AU3038671A (cg-RX-API-DMAC7.html)
AU2503871A (cg-RX-API-DMAC7.html)
AU3025871A (cg-RX-API-DMAC7.html)
AU2577671A (cg-RX-API-DMAC7.html)
AU2588771A (cg-RX-API-DMAC7.html)
AU2654071A (cg-RX-API-DMAC7.html)
AU2456871A (cg-RX-API-DMAC7.html)
AU2669471A (cg-RX-API-DMAC7.html)
AU2455871A (cg-RX-API-DMAC7.html)
AU2684171A (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
V4 Discontinued because of reaching the maximum lifetime of a patent